{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T11:02:44Z","timestamp":1777892564600,"version":"3.51.4"},"reference-count":11,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Royal College of Physicians of Edinburgh"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:p>A 44-year-old female, with a background of cerebral palsy, epilepsy and learning disabilities, presented with multiple seizures and a persistently reduced consciousness level secondary to valproate-induced hyperammonaemic encephalopathy (plasma levels &gt;50 \u03bcg\/dl). Withdrawal of valproate and subsequent infusion of L-carnitine led to full recovery. Nonhepatic hyperammonaemia has been shown to be effectively treated by intravenous L-carnitine therapy by a series of case reports. To date, no randomised controlled trials have demonstrated this. Hyperammonaemic encephalopathy is possibly a more common presentation than expected that is currently underdiagnosed and exacerbated by valproate.<\/jats:p>","DOI":"10.4997\/jrcpe.2019.410","type":"journal-article","created":{"date-parts":[[2019,12,5]],"date-time":"2019-12-05T11:15:08Z","timestamp":1575544508000},"page":"301-303","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":3,"title":["L-Carnitine Supplementation as a Potential Therapy for Suspected Hyperammonaemic Encephalopathy"],"prefix":"10.1177","volume":"49","author":[{"given":"Alex","family":"Khakwani","sequence":"first","affiliation":[{"name":"FY2, Harefield Hospital, Harefield, Uxbridge, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Gannon","sequence":"additional","affiliation":[{"name":"Consultant, Colchester Hospital, Colchester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2019,12,1]]},"reference":[{"key":"bibr1-jrcpe.2019.410","unstructured":"Chawla J. Hyperammonemia Clinical Presentation. 2017. https:\/\/emedicine.medscape.com\/article\/1174503-clinical#b1 (accessed 23\/03\/28)."},{"key":"bibr2-jrcpe.2019.410","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2003.12.011"},{"key":"bibr3-jrcpe.2019.410","doi-asserted-by":"publisher","DOI":"10.1080\/08860220802272613"},{"key":"bibr4-jrcpe.2019.410","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.1980.tb01477.x"},{"key":"bibr5-jrcpe.2019.410","doi-asserted-by":"publisher","DOI":"10.1080\/10428190701509822"},{"key":"bibr6-jrcpe.2019.410","unstructured":"Nice. Epilepsies: diagnosis and management. 1.8 Management. https:\/\/www.nice.org.uk\/guidance\/cg137\/chapter\/1-Guidance#management-2 (accessed 23\/06\/2019)."},{"key":"bibr7-jrcpe.2019.410","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/8512721"},{"key":"bibr8-jrcpe.2019.410","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.56.10.1405"},{"key":"bibr9-jrcpe.2019.410","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1P135"},{"key":"bibr10-jrcpe.2019.410","unstructured":"Medscape. Valproic acid (Rx). https:\/\/reference.medscape.com\/drug\/depakene-stavzor-valproic-acid-343024#showall (accessed 23\/06\/2019)."},{"key":"bibr11-jrcpe.2019.410","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000008117"}],"container-title":["Journal of the Royal College of Physicians of Edinburgh"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.4997\/jrcpe.2019.410","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.4997\/jrcpe.2019.410","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T06:32:07Z","timestamp":1777617127000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.4997\/jrcpe.2019.410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["10.4997\/jrcpe.2019.410"],"URL":"https:\/\/doi.org\/10.4997\/jrcpe.2019.410","relation":{},"ISSN":["1478-2715","2042-8189"],"issn-type":[{"value":"1478-2715","type":"print"},{"value":"2042-8189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]}}}